• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Profound Medical Corp (NQ: PROF )

    8.000 +0.080 (+1.01%)
    Streaming Delayed Price Updated: 11:54 AM EDT, Sep 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 17,757
    Open 7.960
    Bid (Size) 8.010 (1)
    Ask (Size) 8.080 (4)
    Prev. Close 7.920
    Today's Range 7.960 - 8.030
    52wk Range 7.110 - 11.69
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
    Via ACCESSWIRE
    Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
    From Profound Medical Corp.
    Via GlobeNewswire

    Performance

    YTD
    +0.63%
    +0.63%
    1 Month
    -12.57%
    -12.57%
    3 Month
    -7.41%
    -7.41%
    6 Month
    -3.26%
    -3.26%
    1 Year
    -17.18%
    -17.18%

    More News

    Read More
    Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical: Q4 Earnings Insights
    Via Benzinga
    PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Profound Medical Announces Second Quarter 2024 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Annual General Meeting of Shareholders Voting Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
    From Profound Medical Corp.
    Via GlobeNewswire
    PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
    From Profound Medical Corp.
    Via GlobeNewswire
    Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Announces Non-Brokered Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering
    Via Investor Brand Network
    Exposures Product Safety
    Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
    From Profound Medical Corp.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.